A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate
care and labeling has been reaffirmed by the FDA and most other countries.
Considerations for the use of oral sedation in the institutionalized geriatric patient during dental interventions: a review of the literature. (Spec Care Dentist. 1999 Mar-Apr;19(2):56-63.)
>Abstract
>Related Articles
Tweedy CM, Milgrom P, Kharasch ED, Kaakko T, Spieker M, Coldwell SE.
Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients. (J Clin Psychopharmacol. 2001 Jun;21(3):268-72.)
>Abstract
>Related Articles
Raadal M, Coldwell SE, Kaakko T, Milgrom P, Weinstein P, Perkis V, Karl HW.
A randomized clinical trial of triazolam in 3- to 5-year-olds. (J Dent Res. 1999 Jun;78(6):1197-203.)
>Abstract
>Related Articles
Miller RA, Siegelman LI.
Dental anesthetic management of a patient with ventricular arrhythmias. (Anesth Prog. 1998 Spring;45(2):68-73.)
>Abstract
>Related Articles
Coldwell SE, Awamura K, Milgrom P, Depner KS, Kaufman E, Preston KL, Karl HW.
Side effects of triazolam in children. (Pediatr Dent. 1999 Jan-Feb;21(1):18-25.)
>Abstract
>Related Articles
Comparison of triazolam, diazepam, and placebo as outpatient oral premedication for endodontic patients. (J Endod. 1997 Mar;23(3):181-4.)
>Abstract
>Related Articles
Berthold CW, Dionne RA, Corey SE.
Comparison of sublingually and orally administered triazolam for premedication before oral surgery. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Aug;84(2):119-24.)
>Abstract
>Related Articles
